ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA) has reported earnings 21 times since May 06, 2021. The stock moves an average of ±6.60% the day after reporting, closing higher 38.1% of the time. Its largest post-earnings gain was +15.06% (Nov 22, 2021) and its largest decline was -25.66% (May 08, 2023). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings reactions
How ENTA moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±6.60%
Positive %
38.1%
Negative %
61.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 11, 2026 | ☽ POST | -6.36% | open_in_new |
| Feb 09, 2026 | ☽ POST | +2.17% | open_in_new |
| Nov 17, 2025 | ☽ POST | -3.59% | open_in_new |
| Aug 11, 2025 | ☽ POST | +5.7% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±6.60%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 424B5 | 20260702 | open_in_new SEC.gov |
| 8-K | 20260702 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 8-K | 20260618 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| S-8 | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260326 | open_in_new SEC.gov |
| 8-K | 20260326 | open_in_new SEC.gov |
| 4 | 20260313 | open_in_new SEC.gov |
| 4 | 20260313 | open_in_new SEC.gov |
Frequently asked about ENTA earnings
When does ENANTA PHARMACEUTICALS INC report earnings next? expand_more
ENANTA PHARMACEUTICALS INC (ENTA)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ENTA stock move after earnings? expand_more
Over 21 reports, ENTA has moved an average of ±6.60% the session after earnings, closing higher 38.1% of the time.
What was ENTA's biggest post-earnings move? expand_more
ENTA's largest post-earnings gain on record was +15.06% on Nov 22, 2021, and its largest decline was -25.66% on May 08, 2023.
Where can I find ENANTA PHARMACEUTICALS INC's SEC filings? expand_more
All of ENANTA PHARMACEUTICALS INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07